BioSpecifics Technologies (BSTC) Tops Q1 EPS by 5c

May 8, 2014 8:17 AM UTC

BioSpecifics Technologies (NASDAQ: BSTC) reported Q1 EPS of $0.12, $0.05 better than the analyst estimate of $0.07. Revenue for the quarter came in at $2.8 million versus the consensus estimate of $2.46 million.

For earnings history and earnings-related data on BioSpecifics Technologies (BSTC) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings